Clinical Trial Update: Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of setrusumab in pediatric Japanese patients with Osteogenesis Imperfecta is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Setrusumab (setrusumab)

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Osteogenesis Imperfecta | Phase 3 | Status: ACTIVE_NOT_RECRUITING